QIAGEN N.V. (QGEN) Receives FDA Approval for Companion Diagnostic for Colorectal Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KEYS
3. KLAR
4. PANW
5. HD
6. DVLT
7. MRK
8. PGR
9. EPM
10. MRCY

Go back to QIAGEN N.V. (QGEN) Receives FDA Approval for Companion Diagnostic for Colorectal Cancer
Qiagen NV (NYSE: QGEN) Delayed: 44.79 +2.47 (5.84%)
Previous Close $42.32    52 Week High $28.50 
Open $43.44    52 Week Low $19.94 
Day High $44.80    P/E 154.45 
Day Low $43.39    EPS $0.29 
Volume 2,641,264